.Merck trumps incomes expectations, rears purchases outlook on powerful demand for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Forecasts as Keytruda Purchases Rise BloombergMerck Supply: Pharma Titan Posts Strong Results, Yet Expectation Tumbles Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps income as well as sales requirements amidst Keytruda strong point, yet offers combined full-year expectation MarketWatch.